Postoperative death occurred in 1 patient in each group. Vascular complications included anastomotic strictures: 2 portal vein (PV), 1 hepatic artery (HA), and 1 RHV anastomotic strictures; all in GI.
各组术后均有1例死亡。吻合口狭窄血管并发症均在组1发生：2例发生在门静脉，1例在肝动脉，1例在右肝静脉。
Conclusion Double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma may ameliorate symptoms and prolong survival time.
结论中晚期不能切除的原发性肝癌使用肝动脉、门静脉双重插管灌注化疗，可以改善临床症状、延长存活期。
Objective To research the anticoagulants in protecting the portal vein obstruction after splenectomy due to the portal hypertension of hepatic cirrhosis.
目的：探讨肝硬化、门脉高压症行脾切除术后早期应用抗凝药物对预防门静脉血栓的意义。
Hemodynamics of hepatic artery, portal vein and hepatic vein takes place complicated changes under various kinds of pathologic status because of hepatic distinct double blood supply.
肝脏因其独特的双重血供，在各种病理情况下，肝动脉、门脉及肝静脉系统之间的血流动力学发生复杂的变化。
Hepatic artery thrombosis and portal vein thrombosis were observed in one case each.
发生肝动脉血栓形成和发生门静脉血栓形成的患者各发现一例。
Objective To explore the curative effect of double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma.
目的探讨肝动脉、门静脉双重插管区域灌注化疗在中晚期不能切除原发性肝癌应用方法及临床疗效。
Objective To discuss the expression of vascular endothelial growth factor(VEGF)of hepatic VX2 tumor after portal vein occlusion in rabbits.
目的探讨门静脉阻断对兔肝VX2移植瘤血管内皮生长因子（VEGF）表达的影响。
Arteriography revealed enlarged and numerous branches of hepatic artery with abnormal portal vein visualization and varicose coronary vein.
肝动脉造影表现为肝动脉分支增多、增粗，门静脉异常显影及胃冠状静脉曲张。
Methods Liver scanning was performed with a high frequency transducer to measure the velocity acceleration time and resistant index of portal vein and hepatic artery after finishing the anastomosis.
方法选用高频手术专用探头，于手术中门静脉、肝动脉吻合完成后立即测量肝动脉及门静脉血流速度，并计算快速充盈时间及阻力指数。
Conclusion HBO treatment could increase the blood flow of right branch of portal vein, improve hepatic function and alleviate the clinical symptoms and signs of patients with hepatitis.
结论高压氧治疗慢性肝炎可增加患者的门静脉右支血流量，改善肝功能，改善临床症状与体征。
Methods: 49 patients with late liver carcinoma were treated with embolism of hepatic artery and combined with chemotherapy through portal vein were reported.
方法：49 例无手术指征肝癌患者，行单纯肝动脉栓塞与在肝动脉栓塞的基础上行肝门静脉化疗的对照研究。
Objective To investigate the clinical value about hepatic arterial chemoembolization and portal vein continuous perfusion chemotherapy in the treatment of primary liver cancer.
目的探讨肝动脉化疗栓塞加门静脉持续灌注化疗治疗原发性肝癌的临床价值。
Objective: to study the relationship between hepatic encephalopathy and blood flow direction of intra hepatic portal vein after transjugular intrahepatic portosystemic stent shunt (TIPSS).
目的研究经颈静脉途径肝内门体静脉内支架分流术TIPS S术后肝性脑病的发生与门静脉血流方向的关系。
Conclusions the local infusion chemotherapy via hepatic artery and portal vein was an effective therapy for those who could not undergo the resection of advanced liver cancer.
结论肝动脉局部灌注化疗对不能手术切除的晚期肝癌，作为治疗手段不失为一种有效的方法。
Objective To investigate the application of local treatment combining with chemotherapy via portal vein guided by US in advanced hepatic cancer.
目的探讨超声引导下局部治疗结合门静脉化疗在中晚期肝癌中的应用。
Background The hepatic portal blood flow including portal vein often to be occluded temporarily during abdomen operation especially hepatobiliary operation.
腹部手术，尤其是肝胆手术时常需暂时性阻断包括门静脉在内的肝门。
Objective To evaluate the effect of portal vein arterialization on hepatic regeneration.
目的探讨门静脉动脉化重建肝血流后对肝脏再生的影响。
Objective To study the cellular nuclear density difference of the hepatic portal vein between the human and pig and provide evidence for pig- to-human liver xenotransplantation.
目的比较研究人与猪肝门静脉细胞核密度间的异同，为猪与人异种肝移植提供理论依据。
Conclusion the portal vein occlusion may reduce the VEGF expression of hepatic VX2 tumor.
结论门静脉阻断可使兔肝VX2移植瘤的VEGF表达减弱。
Objective To investigate the changes of hepatic portal vein blood flow (PBF) and oxygen metabolism during normothermic or hypothermic cardiopulmonary bypass (CPB).
目的研究常温和低温心肺转流(CPB)期间门静脉血流量(PBF)和氧代谢的变化。
Conclusion the human hepatic portal vein system possibly is close related with the Chong Vessel.
结论：人体肝门静脉系可能与经络冲脉密切相关。
Purpose: To observe the vascular and blood flow changes of portal vein (PV) and hepatic artery (ha) in patients with primary liver carcinoma (PHC).
目的：观察原发性肝癌(PHC)患者的门静脉(PV)、肝动脉(HA)的血管和血流变化。
Objective To study the effect of portal vein blood bypass(PBB) on the tolerance limit of rats with liver cirrhosis to hepatic inflow occlusion(HIO).
目的探讨在门静脉转流条件下肝硬变大鼠耐受入肝血流阻断的安全时限。
Methods By using ultrasound scanner, to compare the flow changes in portal vein and right hepatic artery of diffused hepatic lesions before and after meal with that of normal liver.
方法超声对比检测正常肝与弥漫性肝病进餐前后门静脉和右肝动脉血流改变。
To investigate the diagnostic value of measuring blood velocity in right branch of portal vein and Dopplers onographic waveforms in right hepatic vein by CDFI on Fatty Liver Disease.
肝门静脉血流速度变化及肝右静脉多普勒频谱图异常有助于脂肪肝的早期诊断及预后判断。
The postoperative complications were associated with the change of hepatic blood flow and velocity in the main portal vein.
术后并发症与肝血流、门静脉主干血流速度变化有关。
Objective: To observe the distribution of the Lipiodol Ultra-Fluid (LUF) after portal vein injection in the Wistar rats with hepatic alveolar echinococcosis (HAE) and study the blood supply of HAE.
目的：观察活体碘油灌注在大鼠肝泡球蚴感染模型中的分布，探讨肝泡状棘球蚴病的血供。
Objective: To observe the distribution of the Lipiodol Ultra-Fluid (LUF) after portal vein injection in the Wistar rats with hepatic alveolar echinococcosis (HAE) and study the blood supply of HAE.
目的：观察活体碘油灌注在大鼠肝泡球蚴感染模型中的分布，探讨肝泡状棘球蚴病的血供。
应用推荐